The use of heterologous anti-mouse lymphocyte serum (ALS) in studies of tumorogenic potentials of C3H murine cells propagated in vitro.
D000042:Absorption; D000818:Animals; D000831:Animals, Newborn; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D003601:Cytotoxicity Tests, Immunologic; D004912:Erythrocytes / Q000276:immunology; D006084:Graft Rejection; D006386:Hemagglutination Tests; D007108:Immune Tolerance; D007074:Immunoglobulin G; D007165:Immunosuppression Therapy; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D009368:Neoplasm Transplantation; D011817:Rabbits / Q000276:immunology
D000961:Antilymphocyte Serum; D007074:Immunoglobulin G